TERN Financial Statements

Balance sheet, income statement, cash flow, and dividends for Terns Pharmaceuticals Inc (TERN).


$470.56M Market Cap.

As of 03/20/2025 5:00 PM ET (MRY) • Disclaimer

TERN Market Cap. (MRY)


TERN Shares Outstanding (MRY)


TERN Assets (MRY)


Total Assets

$363.93M

Total Liabilities

$18.06M

Total Investments

$196.72M

TERN Income (MRY)


Revenue

$0

Net Income

-$88.85M

Operating Expense

$101.87M

TERN Cash Flow (MRY)


CF Operations

-$70.02M

CF Investing

-$12.41M

CF Financing

$164.00M

TERN Dividends (MRY)


Period

Dividends

Yield %

Growth %

Payout Ratio

Coverage Ratio

2024

$0

0%

0%

0%

-

2023

$0

0%

0%

0%

-

2022

$0

0%

0%

0%

-

2021

$0

0%

0%

0%

-

2020

$0

-

-

0%

-

TERN Balance Sheet (MRY)


Metric

2024

2023

2022

2021

Total Assets

$363,929,000 (35.53%)

$268,517,000 (-6.45%)

$287,026,000 (70.78%)

$168,070,000 (82.11%)

Assets Current

$362,109,000 (35.40%)

$267,432,000 (-6.23%)

$285,185,000 (70.84%)

$166,930,000 (83.70%)

Assets Non-Current

$1,820,000 (67.74%)

$1,085,000 (-41.06%)

$1,841,000 (61.49%)

$1,140,000 (-19.77%)

Goodwill & Intangible Assets

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Shareholders Equity

$345,870,000 (35.44%)

$255,367,000 (-7.79%)

$276,943,000 (72.76%)

$160,303,000 (236.50%)

Property Plant & Equipment Net

$1,470,000 (42.86%)

$1,029,000 (-42.96%)

$1,804,000 (72.47%)

$1,046,000 (-10.98%)

Cash & Equivalents

$161,439,000 (101.99%)

$79,926,000 (-44.20%)

$143,235,000 (200.29%)

$47,699,000 (-36.28%)

Accumulated Other Comprehensive Income

-$279,000 (-1368.42%)

-$19,000 (97.69%)

-$822,000 (-143.20%)

-$338,000 (-172.58%)

Deferred Revenue

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Total Investments

$196,725,000 (7.20%)

$183,514,000 (31.19%)

$139,879,000 (18.26%)

$118,283,000 (830.04%)

Investments Current

$196,725,000 (7.20%)

$183,514,000 (31.19%)

$139,879,000 (18.26%)

$118,283,000 (830.04%)

Investments Non-Current

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Inventory

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Trade & Non-Trade Receivables

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Trade & Non-Trade Payables

$2,148,000 (-14.59%)

$2,515,000 (52.89%)

$1,645,000 (-22.62%)

$2,126,000 (127.38%)

Accumulated Retained Earnings (Deficit)

-$421,481,000 (-26.71%)

-$332,628,000 (-37.21%)

-$242,418,000 (-33.14%)

-$182,073,000 (-38.02%)

Tax Assets

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Tax Liabilities

$1,490,000 (23.55%)

$1,206,000 (12.61%)

$1,071,000 (36.09%)

$787,000 (19.79%)

Total Debt

$1,347,000 (123.38%)

$603,000 (-49.96%)

$1,205,000 (0%)

$0 (0%)

Debt Current

$428,000 (-29.02%)

$603,000 (-8.77%)

$661,000 (0%)

$0 (0%)

Debt Non-Current

$919,000 (0%)

$0 (0%)

$544,000 (0%)

$0 (0%)

Total Liabilities

$18,059,000 (37.33%)

$13,150,000 (30.42%)

$10,083,000 (29.82%)

$7,767,000 (-67.23%)

Liabilities Current

$15,650,000 (31.03%)

$11,944,000 (41.05%)

$8,468,000 (24.16%)

$6,820,000 (-70.12%)

Liabilities Non-Current

$2,409,000 (99.75%)

$1,206,000 (-25.33%)

$1,615,000 (70.54%)

$947,000 (7.98%)

TERN Income Statement (MRY)


Metric

2024

2023

2022

2021

Revenues

$0 (0%)

$0 (0%)

$0 (0%)

$1,000,000 (0%)

Cost of Revenue

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Selling General & Administrative Expense

$31,759,000 (-18.69%)

$39,061,000 (74.29%)

$22,412,000 (14.65%)

$19,549,000 (117.31%)

Research & Development Expense

$70,112,000 (10.42%)

$63,497,000 (60.28%)

$39,617,000 (26.53%)

$31,311,000 (11.71%)

Operating Expenses

$101,871,000 (-0.67%)

$102,558,000 (65.34%)

$62,029,000 (21.96%)

$50,860,000 (37.37%)

Interest Expense

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Income Tax Expense

$260,000 (8.79%)

$239,000 (-33.24%)

$358,000 (-29.53%)

$508,000 (-37.52%)

Net Loss Income from Discontinued Operations

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Consolidated Income

-$88,853,000 (1.50%)

-$90,210,000 (-49.49%)

-$60,345,000 (-20.31%)

-$50,158,000 (-23.63%)

Net Income to Non-Controlling Interests

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Net Income

-$88,853,000 (1.50%)

-$90,210,000 (-49.49%)

-$60,345,000 (-20.31%)

-$50,158,000 (-25.23%)

Preferred Dividends Income Statement Impact

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Net Income Common Stock

-$88,853,000 (1.50%)

-$90,210,000 (-49.49%)

-$60,345,000 (-20.31%)

-$50,158,000 (-70.88%)

Weighted Average Shares

$79,507,474 (11.57%)

$71,259,239 (97.76%)

$36,033,045 (58.69%)

$22,705,948 (7862.47%)

Weighted Average Shares Diluted

$79,507,474 (11.57%)

$71,259,239 (97.76%)

$36,033,045 (58.69%)

$22,705,948 (7862.47%)

Earning Before Interest & Taxes (EBIT)

-$88,593,000 (1.53%)

-$89,971,000 (-49.98%)

-$59,987,000 (-20.82%)

-$49,650,000 (-26.53%)

Gross Profit

$0 (0%)

$0 (0%)

$0 (0%)

$1,000,000 (0%)

Operating Income

-$101,871,000 (0.67%)

-$102,558,000 (-65.34%)

-$62,029,000 (-24.41%)

-$49,860,000 (-34.67%)

TERN Cash Flow Statement (MRY)


Metric

2024

2023

2022

2021

Net Cash Flow from Investing

-$12,410,000 (67.33%)

-$37,987,000 (-70.56%)

-$22,272,000 (81.39%)

-$119,696,000 (-1888.38%)

Net Cash Flow from Financing

$163,995,000 (290.92%)

$41,951,000 (-74.89%)

$167,095,000 (24.33%)

$134,393,000 (57.16%)

Net Cash Flow from Operations

-$70,016,000 (-3.90%)

-$67,390,000 (-37.23%)

-$49,109,000 (-17.41%)

-$41,827,000 (-40.32%)

Net Cash Flow / Change in Cash & Cash Equivalents

$81,513,000 (228.75%)

-$63,309,000 (-166.27%)

$95,536,000 (451.82%)

-$27,155,000 (-143.46%)

Net Cash Flow - Business Acquisitions and Disposals

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Net Cash Flow - Investment Acquisitions and Disposals

-$12,368,000 (67.40%)

-$37,935,000 (-72.46%)

-$21,997,000 (81.57%)

-$119,356,000 (-1740.18%)

Capital Expenditure

-$42,000 (19.23%)

-$52,000 (81.09%)

-$275,000 (19.12%)

-$340,000 (41.78%)

Issuance (Repayment) of Debt Securities

$0 (0%)

$0 (0%)

$0 (0%)

-$12,880,000 (-176.32%)

Issuance (Purchase) of Equity Shares

$164,383,000 (288.66%)

$42,295,000 (-74.75%)

$167,496,000 (22.01%)

$137,276,000 (114296.67%)

Payment of Dividends & Other Cash Distributions

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Effect of Exchange Rate Changes on Cash

-$56,000 (-147.86%)

$117,000 (165.73%)

-$178,000 (-612.00%)

-$25,000 (-131.25%)

Share Based Compensation

$15,627,000 (-38.80%)

$25,536,000 (137.15%)

$10,768,000 (32.19%)

$8,146,000 (381.73%)

Depreciation Amortization & Accretion

$896,000 (1.70%)

$881,000 (-14.63%)

$1,032,000 (101.56%)

$512,000 (29.95%)

TERN Financial Metrics (MRY)


Metric

2024

2023

2022

2021

Gross Margin

-

-

-

100.00%

Profit Margin

-

-

-

-5015.80%

EBITDA Margin

-

-

-

-4913.80%

Return on Average Equity (ROAE)

-30.50% (8.96%)

-33.50% (-3.72%)

-32.30% (-13.33%)

-28.50% (-207.95%)

Return on Average Assets (ROAA)

-29.10% (8.78%)

-31.90% (-3.24%)

-30.90% (-13.19%)

-27.30% (45.94%)

Return on Sales (ROS)

-

-

-

-4965.00%

Return on Invested Capital (ROIC)

-60.30% (-17.54%)

-51.30% (-5.12%)

-48.80% (-5.17%)

-46.40% (91.65%)

Dividend Yield

0% (0%)

0% (0%)

0% (0%)

0%

Price to Earnings Ratio (P/E)

-4.95 (3.21%)

-5.11 (16.17%)

-6.1 (-90.56%)

-3.2

Price to Sales Ratio (P/S)

-

-

-

160.53

Price to Book Ratio (P/B)

1.36 (-13.31%)

1.57 (13.52%)

1.38 (24.15%)

1.11

Debt to Equity Ratio (D/E)

0.05 (1.96%)

0.05 (41.67%)

0.04 (-25.00%)

0.05 (123.76%)

Earnings Per Share (EPS)

-1.12 (11.81%)

-1.27 (23.95%)

-1.67 (24.43%)

-2.21 (97.85%)

Sales Per Share (SPS)

0 (0%)

0 (0%)

0 (0%)

0.04 (0%)

Free Cash Flow Per Share (FCFPS)

-0.88 (6.87%)

-0.95 (31.00%)

-1.37 (26.17%)

-1.86 (98.26%)

Book Value Per Share (BVPS)

4.35 (21.37%)

3.58 (-53.37%)

7.69 (8.87%)

7.06 (101.71%)

Tangible Assets Book Value Per Share (TABVPS)

4.58 (21.47%)

3.77 (-52.70%)

7.97 (7.62%)

7.4 (-97.71%)

Enterprise Value Over EBIT (EV/EBIT)

-2 (50.00%)

-4 (20.00%)

-5 (-150.00%)

-2

Enterprise Value Over EBITDA (EV/EBITDA)

-2.3 (43.70%)

-4.08 (25.05%)

-5.45 (-135.12%)

-2.32

Asset Turnover

0 (0%)

0 (0%)

0 (0%)

0.01 (0%)

Current Ratio

23.14 (3.34%)

22.39 (-33.52%)

33.68 (37.59%)

24.48 (514.69%)

Dividends

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Free Cash Flow (FCF)

-$70,058,000 (-3.88%)

-$67,442,000 (-36.57%)

-$49,384,000 (-17.12%)

-$42,167,000 (-38.74%)

Enterprise Value (EV)

$201,730,257 (-44.57%)

$363,923,448 (13.27%)

$321,298,779 (182.12%)

$113,888,606

Earnings Before Tax (EBT)

-$88,593,000 (1.53%)

-$89,971,000 (-49.98%)

-$59,987,000 (-20.82%)

-$49,650,000 (-26.53%)

Earnings Before Interest Taxes & Depreciation Amortization (EBITDA)

-$87,697,000 (1.56%)

-$89,090,000 (-51.12%)

-$58,955,000 (-19.98%)

-$49,138,000 (-26.49%)

Invested Capital

$188,187,000 (6.17%)

$177,250,000 (29.83%)

$136,528,000 (20.23%)

$113,551,000 (1415.02%)

Working Capital

$346,459,000 (35.61%)

$255,488,000 (-7.67%)

$276,717,000 (72.83%)

$160,110,000 (135.29%)

Tangible Asset Value

$363,929,000 (35.53%)

$268,517,000 (-6.45%)

$287,026,000 (70.78%)

$168,070,000 (82.11%)

Market Capitalization

$470,561,257 (17.33%)

$401,046,448 (4.74%)

$382,908,779 (114.35%)

$178,639,606

Average Equity

$291,435,250 (8.38%)

$268,906,250 (44.08%)

$186,642,250 (6.08%)

$175,948,250 (258.29%)

Average Assets

$304,952,000 (7.83%)

$282,796,500 (44.81%)

$195,285,250 (6.25%)

$183,802,000 (216.37%)

Invested Capital Average

$147,030,250 (-16.10%)

$175,251,750 (42.57%)

$122,919,750 (14.76%)

$107,108,000 (1416.90%)

Shares

84,938,855 (37.45%)

61,794,522 (64.29%)

37,613,829 (48.86%)

25,267,271 (11.20%)